The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy
Open accessAbstract
Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth, proliferation and metabolism. mTORC1 regulates protein synthesis positively and autophagy negatively. Autophagy is a major system to manage bulk degradation and recycling of cytoplasmic components and organelles. Tuberous sclerosis complex (TSC) 1 and 2 form a heterodimeric complex and inactivate Ras homolog enriched in brain, resulting in inhibition of mTORC1. Here, we investigated the effects of hyperactivation of mTORC1 on cardiac function and structure using cardiac-specific TSC2-deficient (TSC2-/-) mice. TSC2-/- mice were born normally at the expected Mendelian ratio. However, the median life span of TSC2-/- mice was approximately 10 months and significantly shorter than that of control mice. TSC2-/- mice showed cardiac dysfunction and cardiomyocyte hypertrophy without considerable fibrosis, cell infiltration or apoptotic cardiomyocyte death. Ultrastructural analysis of TSC2-/- hearts revealed misalignment, aggregation and a decrease in the size and an increase in the number of mitochondria, but the mitochondrial function was maintained. Autophagic flux was inhibited, while the phosphorylation level of S6 or eukaryotic initiation factor 4E -binding protein 1, downstream of mTORC1, was increased. The upregulation of autophagic flux by trehalose treatment attenuated the cardiac phenotypes such as cardiac dysfunction and structural abnormalities of mitochondria in TSC2-/- hearts. The results suggest that autophagy via the TSC2-mTORC1 signaling pathway plays an important role in maintenance of cardiac function and mitochondrial quantity and size in the heart and could be a therapeutic target to maintain mitochondrial homeostasis in failing hearts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Cardiomyocyte‐specific deletion of Tsc2 | Exacerbated cardiac hypertrophy and premature death after mTORC1 hyperactivation | Taneike et al (2016) |”
From Autophagy in major human diseases (2021) · cites this paper as Taneike et al (2016)
In the citing paper
“In this scenario, the persistent activation of MTORC1 lowers the capacity of cardiomyocytes to sustain pressure overload‐induced stress, as testified to by the fact that mice bearing knock‐in mutation in the MTORC1 inhibitor Tsc2 (TSC complex subunit 2) develop heart disease (Taneike et al, 2016), while succumbing to pressure overload (Ranek et al, 2019).”
From Autophagy in major human diseases (2021) · cites this paper as Taneike et al, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 4×
“mTORC1 inhibits autophagy [4] by phosphorylating unc-51 like autophagy activating kinase 1 (ULK1), a mammalian ortholog of Atg1 [5].”
BackgroundInfluentialAutophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“In autophagy, an isolation membrane sequesters a part of the cytoplasm or organelles including mitochondria to form an autophagosome [6].”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330 · cited 1×
“Since mTORC1 is known to be a negative regulator of autophagy in mammalian cells [4], we estimated the autophagic activity in TSC2 hearts (Fig 3C) [32].”
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · cited 1×
“mitochondria are determined by fusion and fission, followed by autophagy [46].”
BackgroundYoule, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273 · cited 1×
“PINK1 and Parkin are known to be key molecules for damaged mitochondria clearance via ubiquitination and mitophagy in neuron [50].”
BackgroundTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083 · cited 1×
“Akt-mediated phosphorylation of TSC2 inhibits the function of the TSC1/2 complex [14], resulting in activation of mTORC1.”
BackgroundPhosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170 · cited 3×
“mTORC1 positively regulates cell growth and proliferation by promoting biosynthesis of proteins and lipids and mitochondrial metabolism and biogenesis and also by limiting autophagy [1].”
BackgroundInfluential
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
New Insights Into the Role of mTOR Signaling in the Cardiovascular System
Sciarretta, S., Forte, M., Frati, G., & Sadoshima, J. (2018) · Circulation Research · doi:10.1161/circresaha.117.311147 · Cited by 491
“sociated with an impairment of autophagic flux, which were reversed by pharmacological autophagy reactivation.(127)”
Inflammation and metabolic cardiomyopathy
Nishida, K., & Otsu, K. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx012 · Cited by 329
“trehalose treatment attenuated cardiac dysfunction and structural abnormalities of mitochondria in the TSC2-deficient mouse hearts.(107) The”
BackgroundSelf-citationAutophagy in Cardiovascular Aging
Abdellatif, M., Sedej, S., Carmona-Gutierrez, D., Madeo, F., & Kroemer, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312208 · Cited by 239
“Reactivation of autophagy by trehalose treatment attenuated cardiac dysfunction and structural abnormalities of mitochondria in tuberous sclerosis complex 2-deficient hearts.(166) These results suggest that autophagy via the tuberous sclerosis complex 2-mTORC1 signaling pathway”
BackgroundMechanisms contributing to cardiac remodelling
Wu, Q.-Q., Xiao, Y., Yuan, Y., Ma, Z.-G., Liao, H.-H., Liu, C., Zhu, J.-X., Yang, Z., Deng, W., & Tang, Q.-Z. (2017) · Clinical Science · doi:10.1042/cs20171167 · Cited by 210
The role of AMPK in cardiomyocyte health and survival
Bairwa, S. C., Parajuli, N., & Dyck, J. R. B. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.001 · Cited by 148
Bartolomé, A., García-Aguilar, A., Asahara, S.-I., Kido, Y., Guillén, C., Pajvani, U. B., & Benito, M. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00441-17 · Cited by 141
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress
Ranek, M. J., Kokkonen-Simon, K. M., Chen, A., Dunkerly-Eyring, B. L., Vera, M. P., Oeing, C. U., Patel, C. H., Nakamura, T., Zhu, G., Bedja, D., et al. (2019) · Nature · doi:10.1038/s41586-019-0895-y · Cited by 130
Kuno, A., Hosoda, R., Sebori, R., Hayashi, T., Sakuragi, H., Tanabe, M., & Horio, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-33930-w · Cited by 88
Wei, H., Qu, H., Wang, H., Ji, B., Ding, Y., Liu, D., Duan, Y., Liang, H., Peng, C. X., Xiao, X., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.02.007 · Cited by 69
The complex network of mTOR signalling in the heart
Sciarretta, S., Forte, M., Frati, G., & Sadoshima, J. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab033 · Cited by 71
“Conversely, FLCN or TSC2 deletion in the heart leads to cardiac hypertrophy and dysfunction by promoting activation of mTORC1.(150,151) In mice undergoing pressure overload, PKG activation is sufficient to reduce cardiac hypertrophy.”
BackgroundYamaguchi, O. (2019) · Circulation Journal · doi:10.1253/circj.cj-18-1065 · Cited by 69
Self-citationAutophagy and Mitophagy as Essential Components of Atherosclerosis
Poznyak, A. V., Nikiforov, N. G., Wu, W., Kirichenko, T. V., & Orekhov, A. N. (2021) · Cells · doi:10.3390/cells10020443 · Cited by 63
“Notably, such an effect was shown to be alleviated by the treatment with trehalose [16].”
BackgroundAutophagy in cardiovascular health and disease
Abdellatif, M., Ljubojević-Holzer, S., Madeo, F., & Sedej, S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.022 · Cited by 58
Pena, A. Z., Kobir, A., Goncharov, D. A., Goda, A., Kudryashova, T. V., Ray, A., Vanderpool, R. R., Baust, J., Chang, B., Mora, A. L., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0364oc · Cited by 53
“The mTORC1 signaling is a master regulator of protein, lipid, and nucleotide synthesis, up-regulation of which induces cell growth and hypertrophic response (21, 23).”
BackgroundProtein and Mitochondria Quality Control Mechanisms and Cardiac Aging
Ghosh, R., Vinod, V., Symons, J. D., & Boudina, S. (2020) · Cells · doi:10.3390/cells9040933 · Cited by 52
AMPK blunts chronic heart failure by inhibiting autophagy
Li, Y., Wang, Y., Zou, M., Chen, C., Chen, Y., Xue, R., Dong, Y., & Liu, C. (2018) · Bioscience Reports · doi:10.1042/bsr20170982 · Cited by 51
PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy
Oeing, C. U., Nakamura, T., Pan, S., Mishra, S., Dunkerly-Eyring, B. L., Kokkonen-Simon, K. M., Lin, B. L., Chen, A., Zhu, G., Bedja, D., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315714 · Cited by 49
Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells
Xia, Q., Zheng, Y., Jiang, W., Huang, Z., Wang, M., Rodríguez, R., & Jin, X. (2016) · Oncology Letters · doi:10.3892/ol.2016.4880 · Cited by 47
“In yeast and mammalian cells, the Ras and mTOR pathways are two well-known signaling cascades that are sensitive to nutrient status, cell growth and differentiation, and are negatively regulated during programmed cell death (34).”
BackgroundMisaka, T., Murakawa, T., Nishida, K., Omori, Y., Taneike, M., Omiya, S., Molenaar, C., Uno, Y., Yamaguchi, O., Takeda, J., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.11.004 · Cited by 47
Self-citationKatreddy, R. R., Bollu, L. R., Su, F., Xian, N., Srivastava, S., Thomas, R., Dai, Y., Wu, B., Xu, Y., Rea, M. A., et al. (2018) · Oncogenesis · doi:10.1038/s41389-017-0021-7 · Cited by 45
Caloric restriction mimetics for the treatment of cardiovascular diseases
Sciarretta, S., Forte, M., Castoldi, F., Frati, G., Versaci, F., Sadoshima, J., Kroemer, G., & Maiuri, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa297 · Cited by 41
Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy
Davogustto, G., Salazar, R., Vasquez, H. G., Karlstaedt, A., Dillon, W. P., Guthrie, P. H., Martin, J. R., Vitrac, H., Guardia, G. D. L., Vela, D. C., et al. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.05.016 · Cited by 38
New Insights into the Regulation of mTOR Signaling via Ca2+-Binding Proteins
Amemiya, Y., Maki, M., Shibata, H., & Takahara, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043923 · Cited by 31
mTOR signalling: jack-of-all-trades
Hiani, Y. E., Egom, E. E. A., & Dong, X. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0004 · Cited by 30
Cho, J. M., Park, S., Ghosh, R., Ly, K., Ramous, C., Thompson, L., Hansen, M., Mattera, M. S. D. L. C., Pires, K. M. P., Ferhat, M., et al. (2021) · Aging Cell · doi:10.1111/acel.13467 · Cited by 30
“…cardiomyopathy is recapitulated in adult mice by cardiac specific Atg5 deletion (Taneike et al., 2010) and mTORC1 activation (Li et al., 2017; Taneike et al., 2016; Zhou et al., 2013), whereas desmin-related cardiomyopathy, characterized by the accumulation of cytotoxic misfolded proteins,…”
Enhancing Autophagy Diminishes Aberrant Ca2+ Homeostasis and Arrhythmogenesis in Aging Rabbit Hearts
Murphy, K. R., Baggett, B., Cooper, L. L., Lu, Y., O‐Uchi, J., Sedivy, J. M., Terentyev, D. A., & Koren, G. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01277 · Cited by 23
“Previous reports implicate mTOR not only as an important signaling intermediate between the mitochondria and nucleus that helps maintain mitochondrial function, but also a critical regulator of autophagy (Matsui et al., 2007; Taneike et al., 2016).”
BackgroundSterile Inflammation and Degradation Systems in Heart Failure
Nishida, K., & Otsu, K. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0261 · Cited by 26
Self-citationKouzu, H., Tatekoshi, Y., Chang, H.-C., Shapiro, J. S., McGee, W. A., Jesus, A. D., Ben-Sahra, I., Arany, Z., Leor, J., Chen, C., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154491 · Cited by 22
“Cardiacspecific deletion of Tsc1 or Tsc2 leads to death from heart failure at 6 months and 10 months of age, respectively (14, 15), while Sesn1/2/3 triple-KO mice died during the neonatal period owing to failure to activate autophagy (16).”
BackgroundGao, W., Xu, Y., Ge, J., & Chen, F. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4085 · Cited by 17
Intersection of autophagy regulation and circadian rhythms in the heart
Rabinovich-Nikitin, I., Love, M., & Kirshenbaum, L. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166354 · Cited by 17
Sun, S., Hu, Y., Zheng, Q., Guo, Z., Sun, D., Chen, S., Zhang, Y., Liu, P., Lü, J., & Jiang, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26649 · Cited by 15
“It is mainly due to the effect of mTOR on cardiac collagen expression, Smad3, p53/JNK‐mediated apoptosis, autophagy, and inflammatory response.(12,17,19,21) Poly(ADP‐ribose) polymerase 1 (PARP1), the founding subtype of the PARPs enzyme family, attaches the polymers of ADP‐ribose (PAR) to target proteins and consumes…”
BackgroundInfluentialPhosphorylation Modifications Regulating Cardiac Protein Quality Control Mechanisms
Mishra, S., Dunkerly-Eyring, B. L., Keceli, G., & Ranek, M. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.593585 · Cited by 16
Zahedi, S. N., Pourajam, S., Zaker, E., Kouhpayeh, S., Mirbod, S. M., Tavangar, M., Boshtam, M., Kahkesh, K. H., Qian, Q., Zhang, F., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115674 · Cited by 15
The paradox of autophagy in Tuberous Sclerosis Complex
Reis, L. B., Filippi‐Chiela, E. C., Ashton‐Prolla, P., Visioli, F., & Rosset, C. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0014 · Cited by 11
Morales-Carrizales, D. A., Gopar‐Cuevas, Y., Loera‐Arias, M. D. J., Cárdenas, O. S., Montes‐de‐Oca‐Luna, R., García‐García, A., & Rodríguez‐Rocha, H. (2023) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-023-00468-w · Cited by 11
Hyperactivation of mTOR and AKT in a cardiac hypertrophy animal model of Friedreich ataxia
Tong, W.-H., Ollivierre, H., Noguchi, A. C., Ghosh, M. C., Springer, D., & Rouault, T. A. (2021) · Heliyon · doi:10.1016/j.heliyon.2022.e10371 · Cited by 10
“, 2016) and in a Drosophila model of FRDA (Edenharter et al., 2018; Kayyali et al., 2015; Taneike et al., 2016).”
BackgroundInfluentialAutophagy, Oxidative Stress, and Redox Regulation
Ma, J., Yang, L., Ren, J. T., & Yang, J. Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00020-1 · Cited by 10
Iwata, W., Unoki‐Kubota, H., Kato, H., Shimizu, A., Matsumoto, M., Imasawa, T., Igarashi, A., Matsumoto, K., Noda, T., Terauchi, Y., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229397 · Cited by 10
“Similar findings were reported in cardiac-specific Tsc2-deficient mice, which showed structural abnormalities of mitochondria, although the mitochondrial function was maintained [29].”
ResultResveratrol promotes autophagosome elimination via SIRT1 in cardiomyocytes
Kuno, A., Hosoda, R., Saga, Y., Iwahara, N., Tatekoshi, Y., Numazawa, R., & Horio, Y. (2024) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2024.11.006 · Cited by 9
Jeon, Y., Kwon, H., Chung, T., Park, Y. N., Kim, S., Park, J. Y., Kang, K. S., Woo, D.-Y., Kim, T., & Kim, Y. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118181 · Cited by 9
Restored autophagy is protective against PAK3-induced cardiac dysfunction
Ruiz‐Velasco, A., Raja, R., Chen, X., Ganenthiran, H., Kaur, N., Alatawi, N. H. O., Miller, J. M., Abouleisa, R., Ou, Q., Zhao, X., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106970 · Cited by 9
Lahue, C., Wong, E., Dalal, A., Tan, W. L. W., Ren, S. V., Foo, R., Wang, Y., & Rau, C. D. (2025) · Epigenetics · doi:10.1080/15592294.2025.2524411 · Cited by 9
“Although rhabdomyomas have been associated with heart failure [55], the effects of Tsc2 knockdown alone are less clear, with a single article suggesting a possible role in cardiac hypertrophy consistent with our GWAS locus [56].”
Li, D., Zhao, K., Yang, X., Xiao, X., & Tang, S. (2017) · Molecules · doi:10.3390/molecules22040595 · Cited by 8
“It is suggested that autophagy through the TSC2-mTOR pathway plays a critical role in maintaining the cardiac function and quantity of mitochondria [19].”
BackgroundMCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesis
Gui, W., Páral, P., Dhamija, B., Hagag, E., Dusa, M., Humajová, J., Francová, P., Kučka, J., Pankrác, J., Schütz, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66831-4 · Cited by 9
“Dosing and timing of rapamycin may account for this discrepancy 88 . mTORC1 activation via inducible cardiac-speci fi c TSC2 knockdownresultsinhypertrophywithoutcontractiledysfunction 93,94 .”
Autophagy in striated muscle diseases
Bailin, P. L., Zhang, L., Zhang, L., & Han, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1000067 · Cited by 7
“Hypertrophy TSC2 Tsc2-cKO mice TSC2-/- mice show cardiac dysfunction and cardiomyocyte hypertrophy by inhibiting autophagic flux (23)”
BackgroundTrehalose preconditioning for transient global myocardial ischemia in rats
Ando, N., Shingu, Y., Suno, K., & Wakasa, S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.032 · Cited by 4
Rosset, C., Jaeger, M. D. C., Filippi‐Chiela, E. C., Reis, L. B., Sartor, I. T. S., Netto, C. B. O., de Farias, C. B., Roesler, R., & Ashton‐Prolla, P. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0475 · Cited by 2
Suppression of mTOR Signaling by miR ‐302/367 Cluster in Breast Cancer Cells
Alemi, M., Taha, M. F., Bazargani, A., Babaali, V., Nemati, H., & Javeri, A. (2025) · The FASEB Journal · doi:10.1096/fj.202501582r · Cited by 2
Cen, W., Pan, Y., Tang, Y., Yu, J., Xuan, Y., Huang, J., Wei, S., & Zhang, J. (2025) · Immunobiology · doi:10.1016/j.imbio.2025.152907 · Cited by 1
Yang, R., Du, Z., Song, X., Ding, X., Liu, Y., Liang, E., & Liu, X. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123891 · Cited by 1
Magdalon, J. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-19012017-155521
Role of Autophagy in Cardiac Physiology and Pathophysiology
Tan, V. P., & Miyamoto, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00006-7
Shirakawa, M., Yokoe, S., Nakagawa, T., Moriwaki, K., Takeuchi, T., & Asahi, M. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001981
Physiopathologie de l’autophagie au cours du développement embryonnaire chez Caenorhabditis elegans
Jenzer, C. (2016) · theses.fr (ABES) · doi:10.70675/0f29ca47z53a6z4a21z987dz62f95980ab1b
Metadata
- Authors
- Taneike, M., Nishida, K., Omiya, S., Zarrinpashneh, E., Misaka, T., Kitazume-Taneike, R., Austin, R., Takaoka, M., Yamaguchi, O., Gambello, M. J., Shah, A. M., & Otsu, K.
- Affiliations
- King's College London (GB)
- The University of Osaka (JP)
- Emory University (US)
- Corresponding author
- Otsu, Kinya
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-03-29
- Volume
- 11
- Issue
- 3
- Pages
- e0152628
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4811538
- OpenAlex
- W2324750755
- Cited by
- 57
- References
- 57
- Citations by year
- 2025: 7 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 2
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- British Heart Foundation (CH/11/3/29051, RG/11/12/29052, CH/11/3/29051, RG/11/12/29052)
- King's College London
- Medical Research Council (MR/K019031/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- tuberous sclerosis complex 2, mTORC1 hyperactivation, cardiac dysfunction, autophagy, mitochondrial homeostasis, cardiomyocyte hypertrophy, trehalose, S6 phosphorylation, eIF4E-binding protein 1, heart mitochondria, heart failure
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Tuberous Sclerosis Complex 2 Protein, Animals, Autophagy, Enzyme Activation, Heart, Cardiomegaly, Mice, Inbred C57BL, Mitochondria, Heart, Organ Specificity, Phenotype, Protein Biosynthesis, Trehalose, Signal Transduction, Down-Regulation, Up-Regulation, Tumor Suppressor Proteins, Multiprotein Complexes, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.